Qiagen N.V.
Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.
Publicatie datum
28 jan 2015 - 21:59
Statutaire naam
Qiagen N.V.
Titel
QIAGEN reports results for fourth quarter and full-year 2014
Bericht
QIAGEN reports results for fourth quarter and full-year 2014
• Full-year 2014 results: Adjusted net sales of $1.35 billion (+4% CER); adjusted operating income of $312.5 million; and adjusted EPS of $1.00
o Adjusted net sales rise 9% CER excluding U.S. HPV products; free cash flow up 15% to $201.4 million for the year
• Q4 2014 results in line with pre-announcement: Adjusted net sales of $360.8 million (+4% CER), adjusted operating income of $71.6 million; and adjusted EPS of $0.25
o Adjusted net sales rise 10% CER excluding U.S. HPV products
• Growth drivers set to deliver above-market growth and lead QIAGEN portfolio transformation in 2015 during last year of significant U.S. HPV headwinds
• QIAGEN expects to deliver higher 2015 adjusted net sales and earnings at constant exchange rates, but adverse impact from currency movements
Gerelateerde downloads
Datum laatste update: 23 februari 2026